Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

NCT02384733 · tracked via the Priya Life Science Denmark tracker

Sponsor

Danish Breast Cancer Cooperative Group

Phase

Not applicable

Started

2015-03

Last updated

2021-07-08

Condition(s) studied

LymphedemaFibrosis

Investigational drug(s) / intervention(s)

Loco-regional RT

Study summary

The purpose of the study is to investigate the difference in late radiation morbidity between hypofractionated and normofractionated loco-regional breast irradiation irrespective of mastectomy or lumpectomy. In patients who a candidates for a boost, the boost will be provided as a simultaneous integrated boost.

Eligibility

Sex

FEMALE

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: Operated for early node-positive breast cancer with indication for loco-regional breast radiotherapy Exclusion Criteria: Previous radiotherapy to chest wall, pregnant/lactating, comorbidity which may hinder 10 years follow up

Primary outcome measure(s)

Development of ipsilateral arm lymphedema — 3 years
\>=10% increased arm circumference compared to the other arm defines edema

Trial sites (1)

Facility	City	Region	Status
Aarhus University Hospital	Aarhus	Denmark

More Danish Breast Cancer Cooperative Group trials in Denmark

Partial Breast Versus no Irradiation for Women With Early Breast Cancer Recruiting

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer Recruiting

Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy Recruiting

Other trials for the same condition

Effect of Lymphovenous Anastomosis on Lower Limb Lymphedema: Pragmatic Randomized Controlled Trial Recruiting

The Effect of Resistance Exercise in Patients With Lower Limb Lymphedema (the LymphEx Study) Recruiting

Lymphaticovenous Anastomosis as Treatment for Lymphedema Active, not recruiting

Lymphovenous Anastomosis for Breast Cancer Lymphedema Active, not recruiting

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02384733 on ClinicalTrials.gov ↗ ← All trials in Denmark